Early Detection Initiative

Working with the research community to improve early diagnosis of pancreatic cancer, our Early Detection Initiative will involve increased focus and funding for projects that will allow the earlier detection of pancreatic cancer, starting with two new exciting research projects.

“Importantly, our Early Detection Initiative will involve increased focus and funding for projects that will allow for earlier detection of pancreatic cancer, says Michelle Stewart, PanKind CEO. “The importance of detecting the disease earlier, allowing for better outcomes and a greater chance of survival, is the overwhelming message we are hearing from those affected by the disease.  Investing in these innovative pancreatic cancer research projects remains the greatest chance of improved outcomes for patients.”

The initiative aligns to the vision and mission of the Foundation with Chairman Alan McArthur, adding “Since 2008, the Foundation has been committed to making the greatest impact possible for Australians affected by pancreatic cancer and the Early Detection Initiative will bring an even greater focus to the work of our organisation. Our investment in innovative research projects remains one of our key strategic priorities and we believe will take us a step closer to a world free from pancreatic cancer, which is our ultimate goal.”

As the first projects to be funded under this new initiative, PanKind are announcing $465,000 in funding for two new research projects, led by the QIMR Berghofer Medical Research Institute and The Jreissati Family Pancreatic Centre at Epworth. Amongst other objectives, both studies aim to increase the proportion of patients diagnosed with operable disease through early detection. It is hoped that this initial funding opens the doors for increased focus and further funding into the early detection of pancreatic cancer.

Ross McKinnon, Head of the PanKind Scientific Advisory Panel said: “These two interesting and diverse research projects, each with a different approach, represent hope for earlier diagnosis of pancreatic cancer and improved outcomes for patients. The PanKind Scientific Advisory panel were impressed by the focus on data, collaboration and a cross discipline approach to increasing progress of research into the early detection of pancreatic cancer”.

Help fund Early Detection research - Make a Tax time donation